GlassScriptPhysician profile
Misty D Lyke
NPI 1821449018
$2,900.41
in general payments reported to CMS, 2019-2025
29 companies · $791 in 2025
The $791 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.10 · 2022: $1,044 · 2023: $560 · 2024: $490 · 2025: $791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,657 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,656.61 |
| Education | $184.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $453.72 | 2022 | |
| Janssen Biotech, INC. | $350.70 | 2022-2025 | Erleada |
| Astellas Pharma US INC | $270.57 | 2022-2025 | Xtandi |
| Abbvie INC. | $252.99 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $190.06 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $189.48 | 2023-2025 | Orgovyx, Gemtesa |
| Procept Biorobotics Corporation | $153.19 | 2025 | |
| Endo Pharmaceuticals INC. | $116.21 | 2022-2023 | Xiaflex, Edex, Aveed |
| E.R. Squibb & Sons, L.L.C. | $116.13 | 2022 | |
| Coloplast Corp | $98.99 | 2023-2024 | Speedicath |
| Kite Pharma, INC. | $89.28 | 2022 | |
| 180 Medical, INC. | $85.27 | 2022-2024 | Gentlecath |
| Bayer Healthcare Pharmaceuticals INC. | $84.40 | 2022-2025 | |
| Endo USA, INC. | $58.56 | 2025 | Xiaflex, Edex, Aveed |
| Antares Pharma, INC. | $49.35 | 2022-2023 | Xyosted, Nocdurna, Tlando |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $35.07 | 2023-2025 | Eligard |
| C. R. Bard, INC. & Subsidiaries | $32.81 | 2023 | Bard Urinary Drainage Bag |
| Ferring Pharmaceuticals INC. | $30.88 | 2025 | Adstiladrin |
| Rochester Medical Corporation | $29.80 | 2022 | |
| Myovant Sciences INC. | $28.70 | 2022 | |
| Celgene Corporation | $28.63 | 2022 | |
| Boston Scientific Corporation | $28.48 | 2025 | Ams 700 |
| Hollister Incorporated | $26.87 | 2022 | |
| Daiichi Sankyo INC. | $23.19 | 2023 | Enhertu |
| Blue Earth Diagnostics | $17.22 | 2023 | |
| Laborie Medical Technologies Corp. | $16.98 | 2023 | |
| Karyopharm Therapeutics INC. | $15.10 | 2021 | |
| Accord Healthcare, INC. | $14.37 | 2025 | |
| Axonics, INC. | $13.41 | 2024 | Bulkamid, Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Misty Lyke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.